FOLH1 and pachyonychia congenita: The synergistic effect of combining 18F-labeled PSMA and whole-body PET/MR with precise multiparametric assessment of pelvic lesions is of particular benefit to patients with early BCR, when recurrent PC is locally advanced, before it comes to the spread of disease and increase of PSA level.